|
1
|
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu
Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients
infected with 2019 novel coronavirus in Wuhan, China. Lancet.
395:497–506. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wu Z and McGoogan JM: Characteristics of
and Important Lessons From the Coronavirus Disease 2019 (COVID-19)
Outbreak in China: Summary of a Report of 72 314 Cases From the
Chinese Center for Disease Control and revention. JAMA.
323:1239–1242. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Perez L: Acute phase protein response to
viral infection and vaccination. Arch Biochem Biophys. 671:196–202.
2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Vasileva D and Badawi A: C-reactive
protein as a biomarker of severe H1N1 influenza. Inflamm Res.
68:39–46. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Milenkovic M, Hadzibegovic A, Kovac M,
Jovanovic B, Stanisavljevic J, Djikic M, Sijan D, Ladjevic N,
Palibrk I, Djukanovic M, et al: D-dimer, CRP, PCT, and IL-6 Levels
at Admission to ICU Can Predict In-Hospital Mortality in Patients
with COVID-19 Pneumonia. Oxid Med Cell Longev.
2022(8997709)2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gambichler T, Schuleit N, Susok L, Becker
JC, Scheel CH, Torres-Reyes C, Overheu O, Reinacher-Schick A and
Schmidt W: Prognostic Performance of Inflammatory Biomarkers Based
on Complete Blood Counts in COVID-19 Patients. Viruses.
15(1920)2023.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Fawzy M, Ahmed SS and Abdelhady SA:
Assessment of diagnostic and prognostic laboratory biomarkers in
severe COVID-19 patients admitted to intensive care unit. Egypt J
Immunol. 30:1–13. 2023.PubMed/NCBI
|
|
8
|
Gulali A, Buse B, Şeyma Y, Halil B and
Duman TT: Characteristics of Covid-19 infection with the original
SARS-Cov-2 virus and other variants: A comparative review. J Bionic
Mem. 2:96–112. 2022.
|
|
9
|
Wittermans E, Grutters JC, Moeniralam HS,
Ocak G, Paul Voorn G, Bos WJW and van de Garde EMW: Overweight and
obesity are not associated with worse clinical outcomes in COVID-19
patients treated with fixed-dose 6 mg dexamethasone. Int J Obes
(Lond). 46:2000–2005. 2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Bartoletti M, Giannella M, Scudeller L,
Tedeschi S, Rinaldi M, Bussini L, Fornaro G, Pascale R, Pancaldi L,
Pasquini Z, et al: Development and validation of a prediction model
for severe respiratory failure in hospitalized patients with
SARS-CoV-2 infection: A multicentre cohort study (PREDI-CO study).
Clin Microbiol Infect. 26:1545–1553. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
McNeill JN, Lau ES, Paniagua SM, Liu EE,
Wang JK, Bassett IV, Selvaggi CA, Lubitz SA, Foulkes AS and Ho JE:
The role of obesity in inflammatory markers in COVID-19 patients.
Obes Res Clin Pract. 15:96–99. 2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kiss S, Gede N, Hegyi P, Németh D, Földi
M, Dembrovszky F, Nagy B, Juhász MF, Ocskay K, Zádori N, et al:
Early changes in laboratory parameters are predictors of mortality
and ICU admission in patients with COVID-19: A systematic review
and meta-analysis. Med Microbiol Immunol. 210:33–47.
2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Middeldorp S, Coppens M, van Haaps TF,
Foppen M, Vlaar AP, Müller MCA, Bouman CCS, Beenen LFM, Kootte RS,
Heijmans J, et al: Incidence of venous thromboembolism in
hospitalized patients with COVID-19. J Thromb Haemost.
18:1995–2002. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Cui S, Chen S, Li X, Liu S and Wang F:
Prevalence of venous thromboembolism in patients with severe novel
coronavirus pneumonia. J Thromb Haemost. 18:1421–1424.
2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z,
Xiang J, Wang Y, Song B, Gu X, et al: Clinical course and risk
factors for mortality of adult inpatients with COVID-19 in Wuhan,
China: A retrospective cohort study. Lancet. 395:1054–1062.
2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Léonard-Lorant I, Delabranche X, Séverac
F, Helms J, Pauzet C, Collange O, Schneider F, Labani A, Bilbault
P, Molière S, et al: Acute pulmonary embolism in COVID-19 patients
on CT angiography and relationship to D-dimer levels. Radiology.
296:E189–E191. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zou Y, Guo H, Zhang Y, Zhang Z, Liu Y,
Wang J, Lu H and Qian Z: Analysis of coagulation parameters in
patients with COVID-19 in Shanghai, China. Biosci Trends.
14:285–289. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Mucha SR, Dugar S, McCrae K, Joseph D,
Bartholomew J, Sacha GL and Militello M: Coagulopathy in COVID-19:
Manifestations and management. Cleve Clin J Med. 87:461–468.
2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Thachil J, Tang N, Gando S, Falanga A,
Cattaneo M, Levi M, Clark C and Iba T: ISTH interim guidance on
recognition and management of coagulopathy in COVID-19. J Thromb
Haemost. 18:1023–1026. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Abbasi J: Researchers tie severe
immunosuppression to chronic COVID-19 and virus variants. JAMA.
325:2033–2035. 2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Tiecco G, Storti S, Degli Antoni M, Focà
E, Castelli F and Quiros-Roldan E: Omicron genetic and clinical
peculiarities that may overturn SARS-369 CoV-2 pandemic: A
literature review. Int J Mol Sci. 23(1987)2022.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao
Y, Xie C, Ma K, Shang K, Wang W and Tian DS: Dysregulation of
immune response in patients with coronavirus 2019 (COVID-19) in
Wuhan, China. Clin Infect Dis. 71:762–768. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y,
Shi J, Zhou M, Wu B, Yang Z, et al: Risk factors for severity and
mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin
Immunol. 146:110–118. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Bivona G, Agnello L and Ciaccio M:
Biomarkers for prognosis and treatment response in COVID-19
Patients. Ann Lab Med. 41:540–548. 2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Huang I, Pranata R, Lim MA, Oehadian A and
Alisjahbana B: C-reactive protein, procalcitonin, D-dimer, and
ferritin in severe coronavirus disease-2019: A meta-analysis. Ther
Adv Respir Dis. 14(1753466620937175)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Demelo-Rodríguez P, Cervilla-Muñoz E,
Ordieres-Ortega L, Parra-Virto A, Toledano-Macías M,
Toledo-Samaniego N, García-García A, García-Fernández-Bravo I, Ji
Z, de-Miguel-Diez J, et al: Incidence of asymptomatic deep vein
thrombosis in patients with COVID-19 pneumonia and elevated D-dimer
levels. Thromb Res. 192:23–26. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Klok FA, Kruip MJHA, van der Meer NJM,
Arbous MS, Gommers DAMPJ, Kant KM, Kaptein FHJ, van Paassen J,
Stals MAM, Huisman MV and Endeman H: Incidence of thrombotic
complications in critically ill ICU patients with COVID-19. Thromb
Res. 191:145–147. 2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Thachil J and Srivastava A: SARS-2
coronavirus-associated hemostatic lung abnormality in COVID-19: Is
it pulmonary thrombosis or pulmonary embolism? Semin Thromb Hemost.
46:777–780. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z
and Zhang Z: D-dimer levels on admission to predict in-hospital
mortality in patients with Covid-19. J Thromb Haemost.
18:1324–1329. 2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Soni M, Gopalakrishnan R, Vaishya R and
Prabu P: Ddimer level is a useful predictor for mortality in
patients with COVID-19: analysis of 483 cases. Diabetes Metab
Syndr. 14:2245–2249. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Tang Y, Liu J, Zhang D, Xu Z, Ji J and Wen
C: Cytokine storm in COVID-19: The current evidence and treatment
strategies. Front Immunol. 11(1708)2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Hu B, Huang S and Yin L: The cytokine
storm and COVID19. J Med Virol. 93:250–256. 2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Broman N, Rantasärkkä K, Feuth T, Valtonen
M, Waris M, Hohenthal U, Rintala E, Karlsson A, Marttila H, Peltola
V, et al: IL-6 and other biomarkers as predictors of severity in
COVID-19. Ann Med. 53:410–412. 2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Lee DW, Gardner R, Porter DL, Louis CU,
Ahmed N, Jensen M, Grupp SA and Mackall CL: Current concepts in the
diagnosis and management of cytokine release syndrome. Blood.
124:188–195. 2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Luo X, Zhou W, Yan X, Guo T, Wang B, Xia
H, Ye L, Xiong J, Jiang Z, Liu Y, et al: Prognostic value of
C-reactive protein in patients with coronavirus 2019. Clin Infect
Dis. 71:2174–2179. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Visser M, Bouter LM, McQuillan GM, Wener
MH and Harris TB: Elevated C-reactive protein levels in overweight
and obese adults. JAMA. 282:2131–2135. 1999.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Gudowska-Sawczuk M, Wrona A, Gruszewska E,
Cylwik B, Panasiuk A, Flisiak R and Chrostek L: Serum level of
interleukin-6 (IL-6) and N-terminal propeptide of procollagen type
I (PINP) in patients with liver diseases. Scand. J Clin Lab
Investig. 78:125–130. 2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Han MS, White A, Perry RJ, Camporez JP,
Hidalgo J, Shulman GI and Davis RJ: Regulation of adipose tissue
inflammation by interleukin 6. Proc Natl Acad Sci USA.
117:2751–2760. 2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Ponti G, Maccaferri M, Ruini C, Tomasi A
and Ozben T: Biomarkers associated with COVID-19 disease
progression. Crit Rev Clin Lab Sci. 57:389–99. 2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Zeng F, Huang Y, Guo Y, Yin M, Chen X,
Xiao L and Deng G: Association of inflammatory markers with the
severity of COVID-19: A meta-analysis. Int J Infect Dis.
96:467–474. 2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Demirkol ME, Bilgin S, Kahveci G,
Kurtkulagi O, Atak BM, Duman TT and Aktas G: C-reactive
protein-to-lymphocyte ratio is a reliable marker in patients with
COVID-19 infection: the CLEAR COVID study. Cir Cir. 90:596–601.
2022.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Shen X and Guo M: Research progress on the
relationship among high sensitive C reactive protein,
neutrophil-lymphocyte ratio and heart failure. Chin J Cardiovasc
Rehabil Med. 24:676–678. 2015.
|
